Phagos, a Paris-based biotechnology company developing AI-driven bacteriophage therapies as sustainable alternatives to antibiotics, has raised €25 million in Series A funding.
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?